Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice.

Abstract

Cannabinoids produce a number of central nervous system effects via the CB2 receptor (CB2R), including analgesia, antianxiety, anti-reward, hypoactivity and attenuation of opioid-induced respiratory depression. However, the cellular distributions of the CB2Rs in the brain remain unclear. We have reported that CB2Rs are expressed in midbrain dopamine (DA) neurons and functionally regulate DA-mediated behavior(s). Unexpectedly, high densities of CB2-like signaling were also found in a neighboring motor structure - the red nucleus (RN) of the midbrain. In the present study, we systematically explored CB2R expression and function in the RN. Immunohistochemistry and in situ hybridization assays showed high densities of CB2R-immunostaining and mRNA signal in RN magnocellular glutamate neurons in wildtype and CB1-knockout, but not CB2-knockout, mice. Ex vivo electrophysiological recordings in midbrain slices demonstrated that CB2R activation by JWH133 dose-dependently inhibited firing rates of RN magnocellular neurons in wildtype, but not CB2-knockout, mice, while having no effect on RN GABA neurons in transgenic GAD67-GFP reporter mice, suggesting CB2-mediated effects on glutamatergic neurons. In addition, microinjection of JWH133 into the RN produced robust ipsilateral rotations in wildtype, but not CB2-knockout mice, which was blocked by pretreatment with either a CB2 or DA D1 or D2 receptor antagonist, suggesting a DA-dependent effect. Finally, fluorescent tract tracing revealed glutamatergic projections from the RN to multiple brain areas including the ventral tegmental area, thalamus, and cerebellum. These findings suggest that CB2Rs in RN glutamate neurons functionally modulate motor activity, and therefore, constitute a new target in cannabis-based medication development for motor disorders.

• Authors: Hai-Ying Zhang, Hui Shen, Ming Gao, Zegang Ma, Briana J Hempel, Guo-Hua Bi, Eliot L Gardner, Jie Wu, Zheng-Xiong Xi
• Journal: Neuropharmacology (Neuropharmacology) Vol. 189 Pg. 108538 (05 15 2021) ISSN: 1873-7064 [Electronic] England
• PMID: 33789118 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
• Copyright: Published by Elsevier Ltd.

Chemical References

• Cannabinoids
• Receptor, Cannabinoid, CB2
• Glutamic Acid
• 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC

Topics

• Animals
• Cannabinoids (administration & dosage)
• Gene Expression
• Glutamic Acid (metabolism)
• Male
• Mice
• Mice, Inbred C57BL
• Mice, Knockout
• Mice, Transgenic
• Microinjections
• Motor Activity (drug effects, physiology)
• Neurons (drug effects, metabolism)
• Receptor, Cannabinoid, CB2 (agonists, biosynthesis, genetics)
• Red Nucleus (diagnostic imaging, metabolism)